NCT06328621 2026-03-18
Lung Cancer Risk Assessment and Etiology
City of Hope Medical Center
Completed
Clinical Trials
46 trialsNCT01013649 2026-02-23
Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT05730712 2026-02-06
Pertuzumab, Trastuzumab, Hyaluronidase-zzxf and Enzalutamide for Treatment of Metastatic Castration-Resistant Prostate Cancer
Mayo Clinic
Phase 2 Completed
NCT03707574 2026-02-04
Genetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
National Cancer Institute (NCI)
Completed
NCT05918185 2026-02-03
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
Mayo Clinic
Completed
NCT04751383 2026-01-21
Testing the Combination of Two Immunotherapy Drugs (Magrolimab and Dinutuximab) in Patients With Relapsed or Refractory Neuroblastoma or Relapsed Osteosarcoma
National Cancer Institute (NCI)
Phase 1 Completed
NCT06219434 2025-12-08
Evaluation of a Mindfulness Intervention to Prevent Chemo-brain in Women Preparing for Chemotherapy for Breast Cancer
Thomas Jefferson University
Phase NA Completed
NCT06128525 2025-11-28
Prostate Resection After Microwave Ablation (PRAMA)
University of Southern California
Phase NA Completed
NCT03801902 2025-09-23
Testing the Safety of Adding Either Monalizumab (IPH2201) or Oleclumab (MEDI9447) to Durvalumab (MEDI4736) Plus Standard Radiation Therapy for Locally Advanced Non-small Cell Lung Cancer (NSCLC), ARCHON-1 Trial
National Cancer Institute (NCI)
Phase 1 Completed
NCT05945290 2025-09-09
Pre-analytical Factors Affecting ctDNA Analysis in Early and Locally Advanced Breast Cancer
Mayo Clinic
Completed
NCT01149083 2025-08-15
Veliparib With or Without Carboplatin in Treating Patients With Stage III or IV Breast Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT05047926 2025-08-08
Prehabilitation for Stage IIIC-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Patients
Mayo Clinic
Phase NA Completed
NCT05764330 2025-08-06
Weight Loss Interventions to Reduce Cancer Progression in Prostate Cancer Patients Under Active Surveillance
Roswell Park Cancer Institute
Phase NA Completed
NCT04581382 2025-07-10
Radiation Therapy, Plasma Exchange, and Immunotherapy (Pembrolizumab or Nivolumab) for the Treatment of Melanoma
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT06861647 2025-07-10
iSITE
The Wellcome Sanger Institute
Completed
NCT05946668 2025-06-18
Evaluation of Vaginal Microbiome as a Biomarker for the Improvement of Vaginal Health in Women With Breast Cancer, ARISE Study
Ohio State University Comprehensive Cancer Center
Completed
NCT03941860 2025-05-23
Testing the Addition of Ixazomib/Placebo to Lenalidomide in Patients With Evidence of Residual Multiple Myeloma, OPTIMUM Trial
National Cancer Institute (NCI)
Phase 3 Completed
NCT05524844 2025-05-11
The Microbiome, Bile Acids, and Notch in Barrett's Esophagus (BE)
Columbia University
Completed
NCT03396926 2025-02-28
Pembrolizumab, Capecitabine, and Bevacizumab for Treating Colorectal Cancer
University of California, San Francisco
Phase 2 Completed
NCT02828358 2025-02-27
Azacitidine and Combination Chemotherapy in Treating Infants With Acute Lymphoblastic Leukemia and KMT2A Gene Rearrangement
National Cancer Institute (NCI)
Phase 2 Completed
NCT05665725 2025-01-31
Siltuximab for the Prevention of CAR T Cell Related Cytokine Release Syndrome in Patients With CD19 Positive Non-Hodgkin Lymphoma
Ohio State University Comprehensive Cancer Center
Phase 1 Completed
NCT03213678 2025-01-27
Samotolisib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With TSC or PI3K/MTOR Mutations (A Pediatric MATCH Treatment Trial)
National Cancer Institute (NCI)
Phase 2 Completed
NCT01902173 2025-01-14
Uprosertib, Dabrafenib, and Trametinib in Treating Patients With Stage IIIC-IV Cancer
National Cancer Institute (NCI)
Phase 1/2 Completed
NCT02761057 2025-01-13
Testing Cabozantinib, Crizotinib, Savolitinib and Sunitinib in Kidney Cancer Which Has Progressed
National Cancer Institute (NCI)
Phase 2 Completed
NCT05716477 2025-01-09
Blood Test (Guardant Shieldâ„¢) for Screening of Colorectal Cancer in Underserved Patients
Ohio State University Comprehensive Cancer Center
Completed
NCT04865133 2024-12-10
Efficacy and Safety of COVID-19 Vaccine in Cancer Patients
Mayo Clinic
Completed
NCT02700230 2024-09-27
Vaccine Therapy in Treating Patients with Malignant Peripheral Nerve Sheath Tumor That is Recurrent or Cannot Be Removed by Surgery
Mayo Clinic
Phase 1 Completed
NCT03071913 2024-09-27
Blood Brain Barrier Differences in Patients with Brain Tumors Undergoing Surgery
Mayo Clinic
Completed
NCT04183218 2024-08-23
Characterizing Chemo-Radiotherapy Treatment-Related Cardiac Changes
Mayo Clinic
Completed
NCT04067960 2024-08-14
Pharmacogenomics Testing in the Optimal Use of Supportive Care Medications in Stage III-IV Cancer
Mayo Clinic
Phase EARLY_PHASE1 Completed
NCT02595866 2024-08-09
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
National Cancer Institute (NCI)
Phase 1 Completed
NCT03119883 2024-08-09
Dysregulation of Glutamine Activity in the Pathogenesis of Multiple Myeloma
Mayo Clinic
Phase NA Completed
NCT05112627 2024-08-09
Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy
Mayo Clinic
Completed
NCT03513952 2024-07-26
Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma
National Cancer Institute (NCI)
Phase 2 Completed
NCT00557193 2024-07-15
Combination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Children's Oncology Group
Phase 3 Completed
NCT02555189 2024-05-13
Enzalutamide With Ribociclib in Treating Patients With Metastatic Castrate-Resistant, Chemotherapy Naive Prostate Cancer That Retains Retinoblastoma Expression
Thomas Jefferson University
Phase 1/2 Completed
NCT03201458 2024-04-05
Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT02797600 2024-04-02
Community Awareness, Resources and Education (CARE II) Project: Project 1
Ohio State University Comprehensive Cancer Center
Completed
NCT04169022 2024-02-12
CAR-LAM
Centre Hospitalier Universitaire de Besancon
Phase NA Completed
NCT05740501 2023-08-04
Pharmacokinetic Profiling of Pembrolizumab and Nivolumab in Patients With Melanoma and/or Non-Small Cell Lung Cancer
Mayo Clinic
Completed
NCT02560623 2022-11-17
A Minimally-Invasive Sponge on a String Device for Screening for Barrett's Esophagus
Mayo Clinic
Phase NA Completed
NCT01343121 2021-08-13
Gemtrans
The Christie NHS Foundation Trust
Phase NA Completed
NCT01345513 2020-03-23
Feasibility Clinical Study of Targeted and Genome-Wide Sequencing
University Health Network, Toronto
Completed
NCT02001337 2019-11-07
EXPAND
Mayo Clinic
Completed
NCT03121287 2019-08-26
Early Imaging Biomarkers in NSCLC
University of Michigan Rogel Cancer Center
Completed
NCT01075425 2016-04-15
Belinostat and Bortezomib in Treating Patients With Relapsed or Refractory Acute Leukemia or Myelodysplastic Syndrome
Virginia Commonwealth University
Phase 1 Completed